Workers’ compensation cases are likely to continue highlighting the tension between federal and state cannabis laws.
If a CBD manufacturer’s application is validated prior to March 31, 2021, its CBD products can be lawfully sold in the UK throughout the whole period of the risk assessment (2-3 years).
While the Farm Bill is unequivocal about expanding the category of legal hemp to include “extracts”, it does not specify an acceptable upper THC concentration limit, nor explicitly allow or disallow for remediation through removal and destruction of some, or all, of the THC they contain.
Manufacturers of food products containing CBD and other cannabinoid derivatives must submit a Novel Foods application in line with the Novel Foods Regulation in order to sell their products in the European Union.
I recently had an in depth discussion with Maynard Breslow of Dank Discussions Podcast. We discussed a number of important topics currently facing the cannabis industry.
As in 1942 when US farmers were called to action through the Hemp for Victory Campaign to bring back hemp to help during WWII, the Friends of HEMP are calling on the US hemp industry to again prove the incredible potential of hemp in supporting our country during times of crisis.
I recently had a great discussion with Andrew Bish and Chad Frey of the Taking Root hemp podcast. We discussed a number of topics, including FDA claims and how hemp and CBD companies can weather the current financial storm.
A physician’s education about cannabis medicine, and her patient’s treatment options, should not depend on their state of residence. Patient access should be based on sound science and physicians should receive comprehensive and uniform education regardless of the state in which they practice.
My vote for “the next CBD” goes to cannabinol (CBN). This is based on its growing acclaim as a safe sleep aid with few, if any, side effects.